Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Migraine

  Free Subscription


29.09.2025

1 Brain Res
2 Cephalalgia
3 Headache
2 Lancet Neurol


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Brain Res

  1. SHARMA R, Pandey A, Agarwal R, Tripathi S, et al
    Network meta-analysis of migraine therapies: balancing efficacy and safety.
    Brain Res. 2025 Sep 17:149946. doi: 10.1016/j.brainres.2025.149946.
    PubMed         Abstract available


    Cephalalgia

  2. THURAIAIYAH J, Christensen RH, Al-Khazali HM, Wiggers A, et al
    Overlap between perceived triggers, premonitory symptoms and symptom persistence across migraine phases: A REFORM study.
    Cephalalgia. 2025;45:3331024251364234.
    PubMed         Abstract available

  3. ZHAI Q, Li H, Chen Q, Zhang N, et al
    Microglial TRPV2-mediated neuroinflammation promotes central sensitization through microglial polarization in a vestibular migraine mouse model.
    Cephalalgia. 2025;45:3331024251364753.
    PubMed         Abstract available


    Headache

  4. LA N, Rattanapitoon SK, Rattanapitoon NK
    Cardiovascular risk considerations in triptan therapy for migraine: Reflections on the study by Peles et al.
    Headache. 2025 Sep 22. doi: 10.1111/head.15063.
    PubMed        

  5. LEE KH, Liang CS, Yeh PK, Tsai CK, et al
    Insomnia severity in migraine: The role of headache frequency, aura status, and comorbidities-A cross-sectional study.
    Headache. 2025 Sep 19. doi: 10.1111/head.15055.
    PubMed         Abstract available

  6. EZZATI A, Fanning KM, Teichrow D, Urani A, et al
    Headache Assessment via Digital Platform in United States: Baseline study characteristics, diagnosis, and treatment patterns.
    Headache. 2025;65:1428-1438.
    PubMed         Abstract available


    Lancet Neurol

  7. OIE LR, Wergeland T, Salvesen O, Gravdahl GRB, et al
    Candesartan versus placebo for migraine prevention in patients with episodic migraine: a randomised, triple-blind, placebo-controlled, phase 2 trial.
    Lancet Neurol. 2025;24:817-827.
    PubMed         Abstract available

  8. LEE MJ
    Revisiting candesartan: new evidence for an old option in migraine prevention.
    Lancet Neurol. 2025;24:802-803.
    PubMed        


Thank you for your interest in scientific medicine.


AMEDEO Migraine is free of charge.